News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 30, 2018, 07:08 ET United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.

United Therapeutics Corporation (NASDAQ: UTHR) ("United Therapeutics") today announced that it has closed the merger of SteadyMed Ltd. (NASDAQ: STDY) ...


Aug 08, 2018, 20:00 ET United Therapeutics Announces Settlement Of Patent Litigation With Watson Laboratories, Inc. Relating To Tyvaso

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Watson Laboratories, Inc....


Aug 08, 2018, 06:00 ET United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint

United Therapeutics Corporation (NASDAQ: UTHR) today announced that preliminary analysis indicates that the FREEDOM-EV clinical study of Orenitram®...


Aug 07, 2018, 16:00 ET United Therapeutics Corporation To Present At 2018 Wedbush PacGrow Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics,...


Aug 01, 2018, 06:00 ET United Therapeutics Corporation Reports Second Quarter 2018 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the quarter ended June 30, 2018. "Our second quarter net...


Jul 31, 2018, 06:00 ET United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®

United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a New Drug Application...


Jul 26, 2018, 06:00 ET United Therapeutics Corporation To Report Second Quarter 2018 Financial Results Before The Market Opens On Wednesday, August 1, 2018

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2018 financial results before the market opens...


May 02, 2018, 06:00 ET United Therapeutics Corporation Reports First Quarter 2018 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2018. "Our first quarter...


Mar 14, 2018, 06:00 ET United Therapeutics Corporation To Present At Oppenheimer 28th Annual Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United...


Mar 07, 2018, 06:00 ET United Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics,...


Feb 21, 2018, 06:00 ET United Therapeutics Corporation Reports 2017 Fourth Quarter And Annual Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2017. "Our...


Feb 15, 2018, 08:00 ET United Therapeutics Announces Settlement Of Patent Litigation With Actavis Laboratories FL, Inc. Relating To Orenitram

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Actavis Laboratories FL, Inc....


Feb 14, 2018, 06:00 ET United Therapeutics Corporation To Report Fourth Quarter And Annual 2017 Financial Results Before The Market Opens On Wednesday, February 21, 2018

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2017 financial results before the...


Dec 28, 2017, 05:00 ET United Therapeutics Corporation To Present At 36th Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United...


Nov 20, 2017, 05:00 ET United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca®

United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for ...


Oct 25, 2017, 06:00 ET United Therapeutics Corporation Reports Third Quarter 2017 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2017. "Our third...


Oct 23, 2017, 06:00 ET United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso® Inhalation System

United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a new inhalation device,...


Oct 19, 2017, 06:00 ET United Therapeutics Corporation To Report Third Quarter 2017 Financial Results Before The Market Opens On Wednesday, October 25, 2017

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2017 financial results before the market opens...


Sep 19, 2017, 09:00 ET Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds

Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics Corporation (NASDAQ: UTHR) is featured in Forbes magazine's special...


Sep 07, 2017, 20:00 ET United Therapeutics Announces FREEDOM-EV Study Of Orenitram® To Continue As Planned Following Interim Analysis

United Therapeutics Corporation (NASDAQ: UTHR) today announced that the independent data monitoring committee (DMC) for the FREEDOM-EV study of...


Aug 09, 2017, 06:00 ET United Therapeutics Corporation To Present At 2017 Wedbush PacGrow Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United...


Jul 27, 2017, 06:00 ET United Therapeutics Corporation Reports Second Quarter 2017 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2017. "Our second quarter...


Jul 21, 2017, 12:30 ET United Therapeutics Corporation to Report Second Quarter 2017 Financial Results Before The Market Opens on Thursday, July 27, 2017

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2017 financial results before the market opens...


May 31, 2017, 06:00 ET United Therapeutics Corporation To Present At Jefferies 2017 Global Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics,...


Apr 27, 2017, 20:00 ET United Therapeutics Announces $250 Million Share Repurchase Program

United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to $250 million of the...